₹1 lakh crore club:8 stocks join the elite market-cap club in just one month, currently 106 stocks trade above the ₹1 lakh crore mark

Indian equities have surged to new highs, with over 106 stocks now trading with a market capitalisation above ₹1 lakh crore. In the last one month, 8 stocks were added to the list. Stocks such as Max Healthcare rallied over 22% in the last one month, reaching ₹1 lakh crore or more. In the last one month, 8 stocks joined this elite club, including Max Healthcare, Indian Hotels, and Info Edge climbed more than 10% to reach this milestone.

Here’s a glance at the latest entrants to the ₹1 lakh crore market-cap club

In Q1, the company expanded significantly with the launch of a 303-bed hospital in NCR and the integration of 600 beds from recent acquisitions. Additionally, Max Healthcare signed an agreement for a 250-bed hospital in Mohali. The company reported an 18% year-on-year revenue growth, with operating EBITDA rising by 14%. Max Healthcare also acquired a 64% stake in Jaypee Healthcare, adding 576 operational beds to its existing network of over 4,300 beds.

In Q1, revenue from operations grew 3.8% QoQ, driven by growth in Mobility Aftermarket, Power Solutions, and Consumer Goods segments. EBITDA increased by 11.1% QoQ, mainly due to higher revenue and cost efficiency. Profit after tax grew 13.8%, with a positive outlook on the Indian automotive market’s 3-4% annual growth.

The acquisition of Bharat Serums and Vaccines (BSV) has positioned Mankind to expand in the IVF market, and its synergies with BSV are expected to drive significant growth. In Q1FY25, Mankind’s net profit rose 9.9% YoY to ₹543 crore, with revenue up 12.2% to ₹2,893 crore. The company also approved raising funds through Non-Convertible Debentures (NCDs) and Commerical Papers (CPs) worth up to ₹10,000 crore.

IHCL in Q1 reported an all-time high revenue of ₹1,596 crore, with an EBITDA margin of 31%. The company opened six new hotels during the quarter, expanding its portfolio to over 325 properties. IHCL’s RevPAR outperformed the industry, and the company continues to benefit from strong demand in areas like MICE (Meetings, Incentives, Conferences, Exhibitions) and spiritual tourism.

In Q1FY25, the company reported a 47% rise in profit after tax ₹233 crore. The company also saw a 10.78% YoY increase in standalone billings, driven by strong performance in recruitment and real estate segments. The firm remains optimistic about growth in non-IT sectors and increased demand in its matrimony and education platforms.

In Q1FY25, Jindal Steel and Power reported a 21% decline in profit to ₹1,338 crore, due to higher expenses and weak steel demand, Raw material costs surged 22%, impacting the company’s margin. However, the metal sector has a positive outlook, supported by resilient domestic fundamentals and easing input costs as key sector drivers.

The company posted a 33% growth in net profit of ₹364 crore in Q1FY25, with revenue resigning 13% to ₹1,485.8 crore. The company has seen strong volume growth in its core oral care segment and continues to expand its market share through aggressive pricing and margin improvements.

The company delivered solid Q1FY25 results, driven by cost control and increasing patient volumes. It achieved 68% bed occupancy and plans to add 1,500 beds over the next five years. Apollo Hospitals is focusing on refurbishing acquired hospitals, obtaining regulatory approvals for new projects, and optimising its online pharmacy business, the Apollo 24/7 platform.

Conclusion

The strong financial and operating performance, strategic acquisitions, expansions, expectation of recovery in demand and along with other strong fundamentals have helped these stocks to climb up the crucial milestone of the ₹1 lakh crore mark.